French Registry of Acute Coronary Syndrome With or Without ST Elevation 2010 (FAST-MI 2010)
The observatory FAST MI 2010 proposes to establish a cohort of 3500 patients recruited prospectively over a period of 2 months.
Patients will be followed up at 1 month and then followed annually for 10 years.
Patients should have agreed to participate in the study, participation in the protocol, or refusal to participate will not affect the therapeutic approach of the physician. The study of genotypic or phenotypic characteristics will not change the therapeutic approach of health care teams.
|Myocardial Infarction Acute Coronary Syndrome|
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||French Registry of Acute Coronary Syndrome With or Without ST Elevation 2010|
- Survival [ Time Frame: 1 month ]Compare survival in the hospital after admission in Intensive Care Unit in the manner of care
- Survival in long-term [ Time Frame: 10 years ]
Biospecimen Retention: Samples With DNA
|Study Start Date:||October 2010|
|Estimated Study Completion Date:||December 2022|
|Estimated Primary Completion Date:||December 2021 (Final data collection date for primary outcome measure)|
Any patient over 18 years admitted for myocardial infarction (MI) of less than 48 hours, characterized by the typical rise and fall of troponin or CPKMb
This is a multicenter observational study, given to 300 prospective medical facilities, CHU, CHG, CHR, health facility of the Army, including a clinic or intensive care unit entitled to receive emergency ACS. (See attached list 10-6) A questionnaire will be sent to each center before the recruitment center on the type and number of beds (Appendix 10-5)
Patients will be recruited consecutively in the CIAU member during a period of 2 months.
The 1-month follow-up will be done by the referring physician of each ISB, by mail or telephone contact with the treating physician and / or patient.
Annual follow-ups will be conducted during 10 years of clinical research technicians of the French Society of Cardiology, mail and / or telephone contact with the municipalities of birth, treating physicians and patients.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01237418
|European Hospital Georges Pompidou|
|Principal Investigator:||Nicolas Danchin||Assistance Publique - Hôpitaux de Paris|